SEASTAR MEDICAL HOLDING CORP (ICU)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.98+2.41%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ICU
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 1.7 | 1.2 | 0.1 | 0.0 | — | 0.0 | — |
| Cost of Revenues | 0.1 | 0.1 | — | 0.0 | — | — | — |
| Gross Profit | 1.6 | 1.2 | 0.1 | 0.0 | — | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 8.9 | 7.5 | 9.1 | 6.0 | 2.5 | 2.8 | — |
| Operating Income | (14.0) | (12.2) | (17.8) | (14.2) | (11.6) | (4.4) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.0 | 0.2 | 1.1 | 0.6 | 0.2 | — |
| Interest & Investment Income | 0.4 | 0.3 | 0.1 | 0.0 | — | 0.0 | — |
| Net Interest Expenses | — | — | — | 1.1 | — | 0.2 | — |
| Other Non-Operating Income / Expenses | 0.4 | 0.0 | — | — | — | — | — |
| EBT, Incl. Unusual Items | (13.6) | (12.1) | (24.8) | (26.2) | (12.2) | (4.6) | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) | — |
| Net Income | |||||||
| Net Income | (13.6) | (12.2) | (24.8) | (26.2) | (12.2) | (4.6) | — |
| Per Share | |||||||
| Basic EPS | (3.34) | (5.86) | (6.63) | (30.26) | (1.48) | (0.63) | — |
| Diluted EPS | — | — | (6.63) | (30.26) | (1.48) | (0.63) | — |
| Basic Weighted Avg Shares | 4.1 | 2.1 | 3.7 | 0.9 | 8.2 | 7.2 | — |
| Diluted Weighted Avg Shares | — | — | 3.7 | 0.9 | 8.2 | 7.2 | — |
| Supplemental | |||||||
| EBIT | (14.0) | (12.2) | (17.8) | (14.2) | (11.6) | (4.4) | — |
| Effective Tax Rate | — | — | — | 0.0% | -0.0% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.